Works matching IS 00302414 AND DT 2012 AND VI 82 AND IP 2
Results: 10
Front & Back Matter.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. X, doi. 10.1159/000338372
- Publication type:
- Article
Efficacy of Bevacizumab plus Erlotinib for Advanced Hepatocellular Carcinoma and Predictors of Outcome: Final Results of a Phase II Trial.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 67, doi. 10.1159/000335963
- By:
- Publication type:
- Article
A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 75, doi. 10.1159/000329079
- By:
- Publication type:
- Article
Varicella Zoster Virus Infection during Chemotherapy in Solid Cancer Patients.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 126, doi. 10.1159/000334739
- By:
- Publication type:
- Article
Genetic Polymorphisms of FcγRIIa and FcγRIIIa Are Not Predictive of Clinical Outcomes after Cetuximab plus Irinotecan Chemotherapy in Patients with Metastatic Colorectal Cancer.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 83, doi. 10.1159/000335959
- By:
- Publication type:
- Article
Expression Levels of Transcribed Ultraconserved Regions uc.73 and uc.388 Are Altered in Colorectal Cancer.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 114, doi. 10.1159/000336479
- By:
- Publication type:
- Article
Sorafenib Dose Escalation in the Treatment of Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 119, doi. 10.1159/000336082
- By:
- Publication type:
- Article
The Gastrin-Releasing Peptide Receptor as a Marker of Dysplastic Alterations in Cervical Epithelial Cells.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 90, doi. 10.1159/000335955
- By:
- Publication type:
- Article
Breast Cancers Detected by Breast MRI Screening and Ultrasound in Asymptomatic Asian Women: 8 Years of Experience in Taiwan.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 98, doi. 10.1159/000335958
- By:
- Publication type:
- Article
Nomograms for Prognostication of Outcome in Patients with Esophageal and Gastroesophageal Carcinoma Undergoing Definitive Chemoradiotherapy.
- Published in:
- Oncology, 2012, v. 82, n. 2, p. 108, doi. 10.1159/000335951
- By:
- Publication type:
- Article